Connect with us

Technology

Texas A&M Health and BurstIQ Partner to Revolutionize Clinical Genomics Research

Published

on

ENGLEWOOD, Colo., July 17, 2024 /PRNewswire/ — Texas A&M Health and BurstIQ, a leader in advanced data management, today announced a partnership to leverage LifeGraph®, a graph-powered, end-to-end data management platform, to transform clinical research. This collaboration aims to enhance patient and researcher interactions while ensuring the highest standards of patient privacy and data rights.

LifeGraph is set to revolutionize Texas A&M Health’s PROVENANCE clinicogenomics registry programs by empowering all data stakeholders, including researchers, institutional stewards, and patients. Through privacy-preserving techniques, dynamic consent, and federated learning approaches, LifeGraph helps Texas A&M Health mitigate the risks and challenges associated with relying solely on deidentification methods for genomic data governance. This innovative solution ensures a secure and efficient data management system for all involved parties.

Texas A&M Health is leveraging LifeGraph to create a comprehensive patient profile – a LifeGraph – that combines patient and population medical data with genomics, social determinants of health, real-world data, ambient data, and knowledge bases such as ClinGen and PharmGKB. This holistic view will empower researchers with the real-world, contextualized data they need to discover new insights and build computational models for superior clinical decision support. The next-gen collaborative research network will provide external researchers and patients alike with the ability to access research studies that benefit them and make more informed decisions about their participation in genomic research. Ultimately, **Texas A&M Health** aims to strengthen patient-researcher agency in data governance, increase access and trust for underrepresented individuals, accelerate the scale of clinicogenomic research, and enhance the implementation of precision medicine tools, thereby improving patient outcomes and offering a hopeful future for healthcare.

“LifeGraph provides a unique foundation for a modern, data-driven, and scalable approach to collaborative genomics research,” said Rick Silva, PhD, Executive Director of Clinical, Translational, and Industry Collaborations at Texas A&M Health’s Institute of Biosciences and Technology, Center for Precision and Genomic Medicine. “By securely linking clinical and non-clinical data in knowledge graphs and allowing patients to make informed decisions about participating in clinical research across time and the patient journey, we can better support patients, institutional data stewards, and enable researchers to derive more value from data. Now we can harness the power of real-world data to transform clinicogenomics research.”

“We are incredibly excited to partner with Texas A&M Health on this revolutionary initiative,” expressed Frank Ricotta, CEO at BurstIQ. “LifeGraph’s secure handling of sensitive healthcare data opens up new possibilities for transforming research and positively impacting the lives of patients.”

This project will also explore the long-term goal of developing a secure system for sharing this data with external collaborators, ultimately aiming to improve healthcare for all.

About Texas A&M Health

Texas A&M Health is a comprehensive health science center that encompasses five schools: the School of Medicine, the School of Nursing, the Rangel School of Pharmacy, the School of Public Health, and the School of Dentistry. With a mission to improve the health and well-being of individuals and communities through transformational education, innovative research, and impactful service, Texas A&M Health is dedicated to advancing the future of health care and preparing the next generation of health professionals.

The Institute of Biosciences & Technology is a premier research institute within Texas A&M Health, located in the Texas Medical Center in Houston. The institute focuses on cutting-edge research in areas such as precision medicine, genomics, and biotechnology. It aims to translate scientific discoveries into real-world applications to improve health outcomes. The Institute of Biosciences & Technology fosters collaboration among scientists, clinicians, and industry partners to drive innovation and address critical health challenges.

About BurstIQ

LifeGraph® by BurstIQ revolutionizes organizational data with advanced data management, privacy-enhancing technology, and knowledge graphs. The platform transforms data into a powerful asset, eliminating silos and providing a single, secure source of truth. LifeGraph reveals hidden connections within complex data sets, enabling easier analysis, insightful collaboration, and innovative decision-making. Organizations leverage LifeGraph to modernize legacy data repositories, driving value and fostering a culture of innovation for the future.

For more information about how LifeGraph can help you make data your superpower, please connect with us here.

Media Contact:
Leanne Atencio
303-588-0517
380470@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/texas-am-health-and-burstiq-partner-to-revolutionize-clinical-genomics-research-302199330.html

SOURCE BurstIQ

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Immorta Bio to Present New Data on SenoVax™ and StemCell Revivify™ at Biotech Showcase 2025

Published

on

By

Senolytic Immunotherapy and Cellular Rejuvenation platforms are progressing toward clinical development

MIAMI, Jan. 10, 2025 /PRNewswire/ — Immorta Bio Inc., a leader in longevity-focused biotechnologies, announced today that it will present its latest developments at the upcoming Biotech Showcase in San Francisco, CA. The company’s presentation will provide insights into its groundbreaking research and technological advancements aimed at Treating Diseases of Aging and Treating Aging as Disease™.

Details of the presentation are as follows:

Event: Biotech Showcase 2025
Date: January 14, 2025
Time: 4 PM Pacific
Location: Franciscan C, Ballroom Level

Immorta Bio’s innovative platform SenoVax™, a dendritic cell-based vaccine designed to target and eliminate senescent cells. Preclinical studies have demonstrated its potential to transform the tumor microenvironment by clearing these cells, which are associated with aging and disease progression. Furthermore, in animal models of multiple solid tumor cancers (lung, breast, glioma, pancreatic), SenoVax™ induced significant tumor regression by enhancing immune responses, underscoring its promise as a therapeutic solution for both cancer treatment and longevity research.

The company’s StemCell Revivify™, a set of personalized young and immortal progenitor and mesenchymal stem cells have shown an ability to achieve dramatic recovery of failing organs in multiple animal models. Proprietary iPSC-based stem cell therapies have been developed to provide scalable, practical, and economical solutions.

“We are thrilled to showcase our recent progress and share our vision for tackling the diseases of aging as well as the aging itself,” said Dr. Thomas Ichim, President and Chief Scientific Officer of Immorta Bio. “At Immorta Bio, we believe that combining cutting-edge science with a deep understanding of the biology of aging can transform how we address major medical challenges. The Biotech Showcase offers an invaluable platform to engage with innovators, collaborators, and investors while we highlight how our breakthroughs in longevity science are paving the way for healthier, longer lives.”

To learn more about the event, please visit https://informaconnect.com/biotech-showcase/. To schedule a one-on-one with Dr. Thomas Ichim, President and Chief Scientific Officer of Immorta Bio, during the event, please email kbash@immortabio.com

About Immorta Bio
Immorta Bio Inc. is a scientific longevity company developing personalized cellular therapeutics focused on Treating Diseases of Aging and Treating Aging as a Disease™. We are advancing longevity medicine by harnessing patient-derived rejuvenated stem cells and enhanced immune cells, restoring the body’s natural ability to combat cancers and age-related diseases. Our mission is to address the root causes of aging and bring resilience and vitality back to you.

To learn more about Immorta Bio’s research initiatives, visit immortabio.comLinkedIn and X.

Media Contact

David Schull  
Russo Partners
858-717-2310
388575@email4pr.com

Kate Bash
Chief Commercial Officer
Immorta Bio
388575@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/immorta-bio-to-present-new-data-on-senovax-and-stemcell-revivify-at-biotech-showcase-2025-302347953.html

SOURCE Immorta Bio Inc.

Continue Reading

Technology

Breaking Stereotypes: New 3Fun Survey Reveals Media’s Missteps in Polyamory Representation

Published

on

By

NEW YORK, Jan. 10, 2025 /PRNewswire/ — Despite growing visibility, only 11% of polyamorous individuals feel media portrayals align with their real-life experiences, according to a new survey by 3Fun, the leading dating app for open-minded singles and partners seeking like-minded connections. The survey, conducted among 1,312 3Fun users, highlights how media misrepresentation shapes public perceptions, reinforces stereotypes, and impacts user expectations on dating platforms like 3Fun.

Key Findings from the 3Fun Survey:

Limited Representation: Nearly 40% of respondents said they rarely see polyamorous relationships in mainstream media, while 17% reported never seeing them at all.Social Media Influence: Platforms like Instagram and TikTok are driving perceptions of polyamory for 40% of users, far surpassing traditional media like TV and film (10%).Accuracy Issues: Only 11% of respondents described media portrayals as “very accurate,” while 52% rated them as “rarely accurate” or “completely inaccurate.”Mixed Progress: While 39% believe portrayals have improved, 38% said they’ve noticed no change at all.Normalization vs. Stereotypes: Social media is a double-edged sword—40% think it normalizes polyamory, but 34% believe it reinforces harmful stereotypes.Global vs. Local Media: Over 21% noted global media tends to be more open-minded about polyamory than local outlets, which are often conservative or avoid the topic altogether.

“The data from this survey shows how far we still have to go in achieving authentic representation of polyamory in media and pop culture,” said Max Ma, Founder and CEO of 3Fun. “These portrayals don’t just shape public opinion—they directly influence how our users feel about their relationships and their ability to live openly. At 3Fun, we’re dedicated to creating a supportive community where everyone can explore their desires without fear of judgment.”

The Real Impact of Misrepresentation

Nearly half of respondents (47%) identified cultural and societal norms as the biggest barriers to societal acceptance of polyamory—more significant than concerns about media portrayal or visibility. However, respondents emphasized that better representation would lead to:

Easier conversations about polyamory (32%)Improved understanding within their social circles (21%)

Gigi Engle, certified sex and relationship psychotherapist and 3Fun’s resident intimacy expert, echoed this sentiment: “Representation matters. Media has the power to normalize relationships and dismantle stereotypes, but only when done thoughtfully. This survey shows a clear need for creators to approach polyamory with authenticity and care.”

Creating a World Where Love Knows No Limits

The findings highlight the role platforms like 3Fun play in bridging the gap between perception and reality. With over 10 million downloads and 3 million verified active users worldwide, 3Fun provides a safe, inclusive space for polyamorous individuals and couples to connect, explore, and thrive.

Join us in building a community where love is celebrated in all its forms. Download 3Fun today and discover a world where love knows no limits.

For more information, visit www.go3fun.co.

About 3Fun:

3Fun, with over 10 million downloads and 3 million verified active users worldwide, is the leading dating app for open-minded singles and partners to meet like-minded people. The platform provides a safe and inclusive space for users to explore ethical open relationships and polyamory lifestyles, fostering community and connection without judgment. Learn more at www.go3fun.co.

Media Contact:
Britni Ackrivo
backrivo@gregoryfca.com
484-504-9920

View original content:https://www.prnewswire.com/news-releases/breaking-stereotypes-new-3fun-survey-reveals-medias-missteps-in-polyamory-representation-302347759.html

SOURCE 3Fun

Continue Reading

Technology

Powerfleet to Present at the 27th Annual Needham Growth Conference

Published

on

By

WOODCLIFF LAKE, N.J., Jan. 10, 2025 /PRNewswire/ — Powerfleet, Inc. (Nasdaq: AIOT) today announced that management is scheduled to present at the 27th Annual Needham Growth Conference on Tuesday, January 14th at 4:30pmET and meet with investors to discuss how Powerfleet is enacting meaningful business change through effective data insights for its customers and underpinning their digital transformations.  

The link to the live webcast of the Company’s presentation will be available by visiting Powerfleets website at https://ir.powerfleet.com/events-presentations/events.

ABOUT POWERFLEET
Powerfleet (Nasdaq: AIOT; JSE: PWR) is a global leader in the artificial intelligence of things (AIoT) software-as-a-service (SaaS) mobile asset industry. With more than 30 years of experience, Powerfleet unifies business operations through the ingestion, harmonization, and integration of data, irrespective of source, and delivers actionable insights to help companies save lives, time, and money. Powerfleet’s ethos transcends our data ecosystem and commitment to innovation; our people-centric approach empowers our customers to realize impactful and sustained business improvement. The company is headquartered in New Jersey, United States, with offices around the globe. Explore more at www.powerfleet.com. Powerfleet has a primary listing on The Nasdaq Global Market and a secondary listing on the Main Board of the Johannesburg Stock Exchange (JSE).

Powerfleet Investor Contacts
Carolyn Capaccio and Jody Burfening
Alliance Advisors IR
AIOTIRTeam@allianceadvisors.com

Powerfleet Media Contact
Jonathan Bates
jonathan.bates@powerfleet.com
+44 7921 242 892

View original content to download multimedia:https://www.prnewswire.com/news-releases/powerfleet-to-present-at-the-27th-annual-needham-growth-conference-302347520.html

SOURCE Powerfleet

Continue Reading

Trending